Computational models for predicting drug responses in cancer research
Related Experiment Video
Updated: Mar 17, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Abstract:
The computational prediction of drug responses based on the analysis of multiple types of genome-wide molecular data is vital for accomplishing the promise of precision medicine in oncology. This will benefit cancer patients by matching their tumor characteristics to the most effective therapy available. As larger and more diverse layers of patient-related data become available, further demands for new bioinformatics approaches and expertise will arise. This article reviews key strategies, resources and techniques for the prediction of drug sensitivity in cell lines and patient-derived samples. It discusses major advances and challenges associated with the different model development steps. This review highlights major trends in this area, and will assist researchers in the assessment of recent progress and in the selection of approaches to emerging applications in oncology.
Insights
Computational drug response prediction using molecular data is key for precision oncology. This approach matches cancer patients to effective therapies by analyzing tumor characteristics.
Area of Science:
- Oncology
- Bioinformatics
- Genomics
Background:
- Precision medicine in oncology relies on predicting drug responses.
- Analyzing diverse, genome-wide molecular data is crucial for personalized cancer therapy.
- Increasing data complexity necessitates advanced bioinformatics approaches.
Purpose of the Study:
- To review strategies, resources, and techniques for predicting drug sensitivity.
- To discuss advances and challenges in computational drug response prediction models.
- To highlight trends in bioinformatics for oncology drug discovery.
Main Methods:
- Review of computational methods for drug sensitivity prediction.
- Analysis of genome-wide molecular data from cell lines and patient samples.
- Discussion of model development steps and associated challenges.
Main Results:
- Key strategies and resources for drug sensitivity prediction are identified.
- Advances in computational modeling for oncology are highlighted.
- Challenges in developing predictive models are discussed.
Conclusions:
- Computational drug response prediction is vital for precision oncology.
- Further bioinformatics expertise is needed as data layers grow.
- This review aids researchers in selecting appropriate methods for cancer therapy prediction.
Related Concept Videos
Treatment Resistant Cancers
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacodynamic Models: Overview
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

